Company Information: Olympus Corporation<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"7733","DATE":"2025-12-19","longName":"Olympus Corporation","company_name_ja":"\u30aa\u30ea\u30f3\u30d1\u30b9(\u682a)","fullTimeEmployees":28138,"address":"","phone":"","website":"https:\/\/www.olympus.co.jp","industry":"Medical Devices","sector":"Healthcare","regularMarketPrice":1992,"financialCurrency":"","marketCap":2194536,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":1010676000000,"OperatingIncome":100820000000,"operatingMargins":9.9800000000000004,"NetIncome":68172000000,"profitMargins":6.75,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":8.4000000000000004,"recommendationMean":2.5714299999999999,"recommendationKey":"hold","targetMeanPrice":1897.6922999999999,"numberOfAnalystOpinions":14,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-07-01T06:14:11.455426\", \"ticker\": \"7733\", \"ticker_full\": \"7733.T\", \"company_name\": \"OLYMPUS CORPORATION\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 2, \"buy\": 2, \"hold\": 9, \"sell\": 0, \"strong_sell\": 1, \"total_analysts\": 14, \"recommendation_key\": \"hold\", \"recommendation_mean\": 2.57143}, \"target_prices\": {\"has_data\": true, \"current\": 1644.0, \"high\": 2300.0, \"low\": 1600.0, \"mean\": 1897.6923, \"median\": 1850.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-07\", \"eps_estimate\": null, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-05-11\", \"eps_estimate\": 9.2, \"eps_actual\": 22.45, \"surprise_pct\": 143.9}, {\"date\": \"2026-02-12\", \"eps_estimate\": 18.96, \"eps_actual\": 12.87, \"surprise_pct\": -32.12}, {\"date\": \"2025-11-06\", \"eps_estimate\": 16.21, \"eps_actual\": 18.03, \"surprise_pct\": 11.23}, {\"date\": \"2025-08-07\", \"eps_estimate\": 15.82, \"eps_actual\": 7.97, \"surprise_pct\": -49.63}, {\"date\": \"2025-05-12\", \"eps_estimate\": 23.09, \"eps_actual\": 36.56, \"surprise_pct\": 58.34}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 4.27, \"institution_pct\": 58.85, \"major_holders\": [{\"label\": \"\", \"value\": 4.27}, {\"label\": \"\", \"value\": 58.85}, {\"label\": \"\", \"value\": 61.47}, {\"label\": \"\", \"value\": 309.0}], \"institutional_holders\": [{\"holder\": \"Pacer Advisors, Inc.\", \"shares\": 19819, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.0, \"pct_change\": 54.09, \"value\": 32582436}], \"mutualfund_holders\": [{\"holder\": \"Artisan Partners Funds Inc.-Artisan International Value Fund\", \"shares\": 40984300, \"date_reported\": \"2026-03-31\", \"pct_held\": 3.68, \"pct_change\": 1.0, \"value\": 67378189200}, {\"holder\": \"Dodge & Cox Funds-Dodge & Cox International Stock Fund\", \"shares\": 21423000, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.92, \"pct_change\": 0.0, \"value\": 35219412000}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 15510601, \"date_reported\": \"2026-01-31\", \"pct_held\": 1.39, \"pct_change\": -1.1, \"value\": 25499428044}, {\"holder\": \"MFS Series Trust XVII-MFS International Equity Fund\", \"shares\": 13475600, \"date_reported\": \"2026-03-31\", \"pct_held\": 1.21, \"pct_change\": -37.22, \"value\": 22153886400}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 10274777, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.92, \"pct_change\": 2.61, \"value\": 16891733388}, {\"holder\": \"Bridge Builder Trust-Bridge Builder International Equity Fund\", \"shares\": 8796700, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.79, \"pct_change\": 12.8, \"value\": 14461774800}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 7970600, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.72, \"pct_change\": 1.2, \"value\": 13103666400}, {\"holder\": \"MFS SERIES TRUST X-MFS International Intrinsic Value Fund\", \"shares\": 7487200, \"date_reported\": \"2026-02-28\", \"pct_held\": 0.67, \"pct_change\": -1.62, \"value\": 12308956800}, {\"holder\": \"-Price (T.Rowe) International Growth Equity Trust\", \"shares\": 6426300, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.58, \"pct_change\": -11.5, \"value\": 10564837200}, {\"holder\": \"T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Stock Fd.\", \"shares\": 5117000, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.46, \"pct_change\": -0.17, \"value\": 8412348000}]}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, \u0093Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":30,"get_dividend_history_year2":20,"get_dividend_history_year3":18,"get_dividend_history_year4":16,"get_dividend_history_year5":14,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T03:07:55.000806\", \"ticker\": \"7733\", \"ticker_full\": \"7733.T\", \"company_name\": \"OLYMPUS CORPORATION\", \"company_info\": {\"name_en\": \"OLYMPUS CORPORATION\", \"long_name\": \"Olympus Corporation\", \"sector\": \"Healthcare\", \"industry\": \"Medical Devices\", \"website\": \"https:\/\/www.olympus.co.jp\", \"employees\": 28138, \"country\": \"Japan\", \"city\": \"Hachioji\", \"address\": \"2951 Ishikawa-machi\", \"description\": \"Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, \u0093Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 2135.8, \"deviation\": 1.53, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 1914.26, \"deviation\": 13.28, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 1799.51, \"deviation\": 20.5, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 1768.76, \"deviation\": 22.6, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 1010676000000.0, \"revenue_fmt\": \"\u00a51.0T\", \"gross_profit\": 654090000000.0, \"gross_profit_fmt\": \"\u00a56541\u5104\", \"operating_income\": 100820000000.0, \"operating_income_fmt\": \"\u00a51008\u5104\", \"ebit\": 103291000000.0, \"ebit_fmt\": \"\u00a51033\u5104\", \"net_income\": 68172000000.0, \"net_income_fmt\": \"\u00a5682\u5104\", \"eps\": 0, \"operating_margin\": 9.98, \"total_assets\": 1537162000000.0, \"total_assets_fmt\": \"\u00a51.5T\", \"total_equity\": 812040000000.0, \"total_equity_fmt\": \"\u00a58120\u5104\", \"total_debt\": 239576000000.0, \"total_debt_fmt\": \"\u00a52396\u5104\", \"total_cash\": 188038000000.0, \"total_cash_fmt\": \"\u00a51880\u5104\", \"equity_ratio\": 52.83, \"de_ratio\": 0.3, \"current_ratio\": 1.62, \"operating_cf\": 100585000000.0, \"operating_cf_fmt\": \"\u00a51006\u5104\", \"investing_cf\": -87408000000.0, \"investing_cf_fmt\": \"-\u00a5874\u5104\", \"financing_cf\": -87627000000.0, \"financing_cf_fmt\": \"-\u00a5876\u5104\", \"free_cf\": 18162000000.0, \"free_cf_fmt\": \"\u00a5182\u5104\", \"net_margin\": 6.75, \"roe\": 8.4, \"roa\": 4.43}, {\"year\": 2025, \"revenue\": 997332000000.0, \"revenue_fmt\": \"\u00a59973\u5104\", \"gross_profit\": 683697000000.0, \"gross_profit_fmt\": \"\u00a56837\u5104\", \"operating_income\": 161996000000.0, \"operating_income_fmt\": \"\u00a51620\u5104\", \"ebit\": 165911000000.0, \"ebit_fmt\": \"\u00a51659\u5104\", \"net_income\": 117855000000.0, \"net_income_fmt\": \"\u00a51179\u5104\", \"eps\": 102.8, \"operating_margin\": 16.24, \"total_assets\": 1433273000000.0, \"total_assets_fmt\": \"\u00a51.4T\", \"total_equity\": 751733000000.0, \"total_equity_fmt\": \"\u00a57517\u5104\", \"total_debt\": 229102000000.0, \"total_debt_fmt\": \"\u00a52291\u5104\", \"total_cash\": 252532000000.0, \"total_cash_fmt\": \"\u00a52525\u5104\", \"equity_ratio\": 52.45, \"de_ratio\": 0.3, \"current_ratio\": 1.6, \"operating_cf\": 190463000000.0, \"operating_cf_fmt\": \"\u00a51905\u5104\", \"investing_cf\": -65469000000.0, \"investing_cf_fmt\": \"-\u00a5655\u5104\", \"financing_cf\": -211542000000.0, \"financing_cf_fmt\": \"-\u00a52115\u5104\", \"free_cf\": 125254000000.0, \"free_cf_fmt\": \"\u00a51253\u5104\", \"net_margin\": 11.82, \"roe\": 15.68, \"roa\": 8.22}, {\"year\": 2024, \"revenue\": 925752000000.0, \"revenue_fmt\": \"\u00a59258\u5104\", \"gross_profit\": 618432000000.0, \"gross_profit_fmt\": \"\u00a56184\u5104\", \"operating_income\": 51745000000.0, \"operating_income_fmt\": \"\u00a5517\u5104\", \"ebit\": 53907000000.0, \"ebit_fmt\": \"\u00a5539\u5104\", \"net_income\": 242566000000.0, \"net_income_fmt\": \"\u00a52426\u5104\", \"eps\": 199.44, \"operating_margin\": 5.59, \"total_assets\": 1534216000000.0, \"total_assets_fmt\": \"\u00a51.5T\", \"total_equity\": 757186000000.0, \"total_equity_fmt\": \"\u00a57572\u5104\", \"total_debt\": 299616000000.0, \"total_debt_fmt\": \"\u00a52996\u5104\", \"total_cash\": 340933000000.0, \"total_cash_fmt\": \"\u00a53409\u5104\", \"equity_ratio\": 49.35, \"de_ratio\": 0.4, \"current_ratio\": 1.85, \"operating_cf\": 42365000000.0, \"operating_cf_fmt\": \"\u00a5424\u5104\", \"investing_cf\": 359992000000.0, \"investing_cf_fmt\": \"\u00a53600\u5104\", \"financing_cf\": -276010000000.0, \"financing_cf_fmt\": \"-\u00a52760\u5104\", \"free_cf\": -22259000000.0, \"free_cf_fmt\": \"-\u00a5223\u5104\", \"net_margin\": 26.2, \"roe\": 32.04, \"roa\": 15.81}, {\"year\": 2023, \"revenue\": 881923000000.0, \"revenue_fmt\": \"\u00a58819\u5104\", \"gross_profit\": 596849000000.0, \"gross_profit_fmt\": \"\u00a55968\u5104\", \"operating_income\": 186118000000.0, \"operating_income_fmt\": \"\u00a51861\u5104\", \"ebit\": 190469000000.0, \"ebit_fmt\": \"\u00a51905\u5104\", \"net_income\": 143432000000.0, \"net_income_fmt\": \"\u00a51434\u5104\", \"eps\": 113.08, \"operating_margin\": 21.1, \"total_assets\": 1508701000000.0, \"total_assets_fmt\": \"\u00a51.5T\", \"total_equity\": 640085000000.0, \"total_equity_fmt\": \"\u00a56401\u5104\", \"total_debt\": 340057000000.0, \"total_debt_fmt\": \"\u00a53401\u5104\", \"total_cash\": 169329000000.0, \"total_cash_fmt\": \"\u00a51693\u5104\", \"equity_ratio\": 42.43, \"de_ratio\": 0.53, \"current_ratio\": 1.57, \"operating_cf\": 98490000000.0, \"operating_cf_fmt\": \"\u00a5985\u5104\", \"investing_cf\": -58414000000.0, \"investing_cf_fmt\": \"-\u00a5584\u5104\", \"financing_cf\": -143178000000.0, \"financing_cf_fmt\": \"-\u00a51432\u5104\", \"free_cf\": 27867000000.0, \"free_cf_fmt\": \"\u00a5279\u5104\", \"net_margin\": 16.26, \"roe\": 22.41, \"roa\": 9.51}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 90.17, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 14.0}, {\"year\": 2023, \"amount\": 16.0}, {\"year\": 2024, \"amount\": 18.0}, {\"year\": 2025, \"amount\": 20.0}, {\"year\": 2026, \"amount\": 30.0}], \"latest\": 30.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-6918","company","type-company","status-publish","hentry"],"yoast_head":"\n